Home > Press > Kylin Therapeutics Signs Collaboration with Fort Dodge Animal Health, a Division of Wyeth
Kylin To Use Its pRNA Technology to Help Develop New RNAi Therapeutics to Treat Cancer
Kylin Therapeutics Signs Collaboration with Fort Dodge Animal Health, a Division of Wyeth
WEST LAFAYETTE, IN | Posted on September 20th, 2007
Kylin Therapeutics, Inc., a biotechnology company, announced it has signed a collaboration with Fort Dodge Animal Health, a division of Wyeth (NYSE:WYE), to develop new RNAi therapeutics for the treatment of cancer. Under the terms of the three-year contract, Kylin will receive research funding, milestone payments and royalties.
Under this contract, Kylin will use its patented RNA nanoparticle technology called "pRNA" to explore the enormous potential of RNA interference (RNAi) and develop new RNA-based therapeutics for the treatment of cancer. In return for its participation in this effort, Fort Dodge will receive an exclusive license to the pRNA/RNAi therapeutic compounds for the treatment of cancers in companion animals. Kylin will retain rights to the therapies for human use.
"We are delighted to welcome Fort Dodge/Wyeth as Kylin's partner. Our business models are complementary, and the results of this effort will provide valuable data and intellectual property that will mutually serve our core businesses," said J. Eric Davis, J.D., president and CEO of Kylin Therapeutics.
The pRNA technology was developed by Peixuan Guo at Purdue University.
About Kylin Therapeutics, Inc.
About Kylin Therapeutics
Kylin ( http://www.kylintherapeutics.com ), which is based at the Purdue Research Park, is a leading biotechnology company focused on delivery and development of RNAi based therapeutics. The company employs its revolutionary RNA nanotechnology platform called "pRNA" to develop the potential of RNA interference (RNAi) to treat many common diseases. Kylin's technology platform has the potential to meet the growing market for treating cancer, HIV and other diseases with RNA-based therapeutics.
About Fort Dodge/Wyeth
Fort Dodge Animal Health is a leading manufacturer and distributor of animal health products for the livestock, companion animal, equine, swine and poultry industries in North America and international markets. Key products include CYDECTIN® Pour-On, QUEST® Gel, the Duramune and Fel-O-Vax® vaccine lines, and West-Nile Innovator® equine vaccines. Fort Dodge is headquartered in Overland Park, Kan.
For more information, please click here
Purdue Research Foundation
Marketing and Communication Contact:
Cynthia Sequin, 765-494-4192 (office)
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Novel nanoparticles could save soldiers' lives after explosions April 15th, 2015
Nanoparticles at specific temperature stimulate antitumor response: Dartmouth researchers identify precise heat to boost immune system against cancer tumors April 14th, 2015
Iranian Scientists Evaluate Dynamic Interaction between 2 Carbon Nanotubes April 14th, 2015
Gold by special delivery intensifies cancer-killing radiation April 13th, 2015
Protein Building Blocks for Nanosystems: Scientists develop method for producing bio-based materials with new properties April 17th, 2015
Oxford Instruments commissions high field outsert magnet system for the National High Magnetic Field Laboratory 32 Tesla magnet program April 17th, 2015
Newly-Developed Nanocatalysts Increase Performance of Fuel Cells April 16th, 2015
Lanthanide-Organic Framework Nanothermometers Prepared by Spray-Drying April 16th, 2015
How can you see an atom? (video) April 10th, 2015
FibeRio and VF Corporation Form Strategic Partnership to Lead the Apparel and Footwear Markets in Nanofiber Technology April 8th, 2015
UK National Graphene Institute Selects Bruker as Official Partner: World-Leading Graphene Research Facility Purchases Multiple Bruker AFMs April 7th, 2015
NXP and GLOBALFOUNDRIES Announce Production of 40nm Embedded Non-Volatile Memory Technology: Co-developed technology to leverage GLOBALFOUNDRIES 40nm process technology platform March 24th, 2015
Light in a spin: Researchers demonstrate angular accelerating light April 15th, 2015
Graphene pushes the speed limit of light-to-electricity conversion: Researchers from ICFO, MIT and UC Riverside have been able to develop a graphene-based photodetector capable of converting absorbed light into an electrical voltage at ultrafast timescales April 14th, 2015
Scientists create invisible objects without metamaterial cloaking April 14th, 2015
Solution-grown nanowires make the best lasers April 14th, 2015